Literature DB >> 11700025

RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells.

H Zill1, R Günther, H F Erbersdobler, U R Fölsch, V Faist.   

Abstract

RAGE (receptor for advanced glycation end products) is a multiligand cell surface molecule of the immunoglobulin superfamily. It was originally described as a receptor for protein adducts formed by glycoxidation (AGEs) that accumulate in diseases such as diabetes and renal failure. Performing RT-PCR and Western blot analysis we intended to determine RAGE expression in the human colon adenocarcinoma cell line Caco-2. Moreover, Caco-2 cells were incubated in the presence of AGEs. Since RAGE ligation triggers the p21(ras) signal transduction pathway the activation state of p44/42 (ERK1/2) MAP kinases was determined. Here we demonstrate for the first time that Caco-2 cells express RAGE and that administration of the food-derived casein-linked AGE N(epsilon)-(carboxymethyl)lysine (Cas-CML) results in Caco-2 p44/42 (ERK1/2) MAP kinase activation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700025     DOI: 10.1006/bbrc.2001.5901

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Advanced glycation end products, diabetes and ageing.

Authors:  N Nass; B Bartling; A Navarrete Santos; R J Scheubel; J Börgermann; R E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

2.  A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.

Authors:  Liang Chen; Zhigang Duan; Lesley Tinker; Haleh Sangi-Haghpeykar; Howard Strickler; Gloria Y F Ho; Marc J Gunter; Thomas Rohan; Craig Logsdon; Donna L White; Kathryn Royse; Hashem B El-Serag; Li Jiao
Journal:  Cancer Epidemiol       Date:  2016-04-18       Impact factor: 2.984

3.  The molecular basis of peanut allergy.

Authors:  Geoffrey A Mueller; Soheila J Maleki; Lars C Pedersen
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

4.  Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.

Authors:  Qibin Zhang; Matthew E Monroe; Athena A Schepmoes; Therese R W Clauss; Marina A Gritsenko; Da Meng; Vladislav A Petyuk; Richard D Smith; Thomas O Metz
Journal:  J Proteome Res       Date:  2011-06-10       Impact factor: 4.466

5.  Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.

Authors:  Li Jiao; Philip R Taylor; Stephanie J Weinstein; Barry I Graubard; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-28       Impact factor: 4.254

Review 6.  The RAGE/multiligand axis: a new actor in tumor biology.

Authors:  Armando Rojas; Ivan Schneider; Cristian Lindner; Ileana Gonzalez; Miguel A Morales
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

7.  Effect of Maillard reaction on biochemical properties of peanut 7S globulin (Ara h 1) and its interaction with a human colon cancer cell line (Caco-2).

Authors:  Małgorzata Teodorowicz; Ewa Fiedorowicz; Henryk Kostyra; Harry Wichers; Elżbieta Kostyra
Journal:  Eur J Nutr       Date:  2013-01-20       Impact factor: 5.614

Review 8.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Authors:  Qibin Zhang; Jennifer M Ames; Richard D Smith; John W Baynes; Thomas O Metz
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

9.  Identification of Maillard reaction products on peanut allergens that influence binding to the receptor for advanced glycation end products.

Authors:  G A Mueller; S J Maleki; K Johnson; B K Hurlburt; H Cheng; S Ruan; J B Nesbit; A Pomés; L L Edwards; A Schorzman; L J Deterding; H Park; K B Tomer; R E London; J G Williams
Journal:  Allergy       Date:  2013-11-23       Impact factor: 13.146

10.  Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice.

Authors:  A M E Bruynzeel; M A Abou El Hassan; C Schalkwijk; J Berkhof; A Bast; H W M Niessen; W J F van der Vijgh
Journal:  Br J Cancer       Date:  2007-02-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.